RecruitingNCT06289270

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Profiling Urinary Microbiota in Male Patients With Bladder Cancer- An Exploratory Study.


Sponsor

Theodor Bilharz Research Institute

Enrollment

38 participants

Start Date

Sep 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Microbes inhabiting the urinary tract that are playing an important role in maintenance of health and the development of diseases and bladder cancer. There is correlation between initiation of bladder cancer and microbes. Urine and bladder tissues from healthy individuals and patients with bladder cancer were analyzed using 16S rRNA sequencing, results show abundant phylum. Next-generation sequencing technologies will be applied with whole genomic and 16S ribosomal RNA gene sequencing for microbiota profiling in urine and bladder tissue of male healthy individuals and patients with bladder cancer. Results will lead to prevention, diagnosis, and new treatment strategies for bladder cancer.


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria3

  • Adult men above 18 years,
  • Diagnosed of carcinoma of the bladder with imaging ultrasonography and/ or computerized tomography, and urine cytology.
  • Confirmed bladder cancer either during diagnostic cystoscopy, previous pathology, or pathological examination of the biopsy specimens.

Exclusion Criteria3

  • \- Previous radiotherapy to the bladder or to adjacent organ.
  • Previous intravesical instillation immunotherapy with bacillus Calmette-Guérin (BCG), or intravesical instillation of chemotherapeutics.
  • Previous neoadjuvant chemotherapy.

Locations(2)

Theodor Bilharz Research Institute

Cairo, Giza Governorate, Egypt

Theodor Bilharz Research Institute

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06289270